Loading companies…
Loading companies…
United States · Biotech
Develops allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven deg...
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed | $140M | Crescendo Equity Partners — Role not disclosedSkylake Equity Partners — Role not disclosed |